Dr. Stover is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1145 Olentangy River Rd
Columbus, OH 43212Phone+1 614-293-0066Fax+1 614-293-7264
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2015
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2008 - 2012
- Vanderbilt University School of MedicineClass of 2008
Certifications & Licensure
- OH State Medical License 2017 - 2026
- MA State Medical License 2012 - 2019
- TN State Medical License 2010 - 2013
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer.Vishnu Prasath, Hinda Boutrid, Robert Wesolowski, Mahmoud Abdel-Rasoul, Cynthia Timmers
Breast Cancer Research and Treatment. 2024-12-07 - Proinflammatory Dietary Pattern and Risk of Total and Subtypes of Breast Cancer Among U.S. Women.Andrea Romanos-Nanclares, Walter C Willett, Bernard Rosner, Daniel G Stover, Sagar D Sardesai
Journal of the National Cancer Institute. 2024-11-20 - Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer.Lauren D Otto-Dobos, Lindsay D Strehle, Brett R Loman, Melina M Seng, Sagar D Sardesai
NPJ Breast Cancer. 2024-11-15
Journal Articles
- Tumor Fraction in Cell-Free DNA as a Biomarker in Prostate CancerHeather A. Parsons, Atish D. Choudhury, Lauren C. Harshman, Daniel G. Stover, The Journal of Clinical Investigation
Press Mentions
- New Hormonal Treatment Orserdu Approved for Metastatic Breast CancerFebruary 13th, 2023
- Twitter: Dr Toni Choueiri – FDA Approve Pembrolizumab Top Tweet Q4 2021November 4th, 2021
- De-Escalation of Radiation Therapy in Patients with Stage I, Node-Negative, HER2-Positive Breast CancerMarch 25th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: